Talniflumate (Genaera).
Article Details
- CitationCopy to clipboard
Knight D
Talniflumate (Genaera).
Curr Opin Investig Drugs. 2004 May;5(5):557-62.
- PubMed ID
- 15202731 [ View in PubMed]
- Abstract
Talniflumate, an anti-inflammatory molecule that was originally developed by Laboratorios Bago, is currently being developed by Genaera as a mucoregulator for the treatment of cystic fibrosis, chronic obstructive pulmonary disease and asthma. Phase I trials with talniflumate had been completed by August 2001, and phase II trials were underway in Ireland for the treatment of cystic fibrosis.
DrugBank Data that Cites this Article
- Drugs